Next Generation News and Research

RSS

BioImagene, KUMC partner to develop Companion Algorithms for digital pathology

BioImagene, Inc., the leading provider of innovative digital pathology solutions, announced a collaboration with the University of Kansas Medical Center (KUMC) Department of Pathology & Laboratory Medicine to develop Companion Algorithms™ for next generation companion diagnostics for digital pathology.

1 Jul 2010

Pre-clinical data of BiTE antibody technology published in PNAS

Micromet, Inc., today announced the publication of pre-clinical data in the Proceedings of the National Academy of Sciences, demonstrating the potency of new product candidates based on the Company's proprietary BiTE antibody technology. BiTE antibodies are a new class of agents designed to harness a patient's T cells to kill cancer cells.

1 Jul 2010

Roche, IBM announce agreement to develop nanopore-based sequencer for decoding human DNA

Roche and IBM announced today an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM's recently published "DNA Transistor" technology, the collaboration will take advantage of IBM's leadership in microelectronics, information technology and computational biology and Roche's expertise in medical diagnostics and genome sequencing.

1 Jul 2010

Biomerix receives FDA 510(k) Clearance to market Ventral Hernia Repair Mesh

Biomerix Corporation announced today that it has received U.S. Food and Drug Administration 510(k) Clearance to market its Biomerix Ventral Hernia Repair Mesh, the latest addition to its innovative portfolio of soft tissue repair devices. The Biomerix Ventral Hernia Repair Mesh, with two distinctly different sides, is the first and only device featuring the Biomerix Biomaterial on one side, designed to promote tissue ingrowth, and a resorbable protective film on the other side, designed to minimize tissue attachment to the device in case of direct contact with the viscera.

1 Jul 2010

SeqWright, RainDance Technologies partner to offer RainStorm microdroplet-based PCR technology

SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.

30 Jun 2010

InNexus develops IXS312 small protein fragment as topical therapy for AMD, diabetic retinal dysplasia

InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced that it has developed IXS312(VEGF), an antibody fragment with activity against the growth factor VEGF for planned use in ocular treatments.

30 Jun 2010

Zymeworks closes $3.2 million financing round

Zymeworks Inc., a privately held biotechnology company focused on the development of next generation antibody-based therapeutics, today announced the close of a financing totaling $3.2 million. The financing consists of a follow-on round of institutional investment by CTI Life Sciences Fund, L.P. ("CTI") which led the Company's previous financing in 2009.

29 Jun 2010

PROLOR Biotech receives EU GMP certification for hGH-CTP biobetter version of human growth hormone

PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that it has received formal Good Manufacturing Practice (GMP) certification for hGH-CTP, the company's proprietary biobetter version of human growth hormone. GMP certification is required by the European Union (EU) clinical trials legislation as a precondition for conducting clinical trials in EU member countries.

29 Jun 2010

FDA grants AMS clearance for MiniArc Precise Single-Incision Sling System

American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the Food and Drug Administration (FDA) has cleared the MiniArc® Precise Single-Incision Sling System, a product for the treatment of female stress urinary incontinence (SUI). MiniArc Precise is the next generation sling in the MiniArc family sling system, the number one selling single-incision sling in the United States.

29 Jun 2010

MorphoSys, Xencor sign worldwide exclusive license, collaboration agreement for XmAb5574 antibody program

MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced today the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development. The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignancies.

28 Jun 2010

Quality Systems’ ad campaign for NextDDS solution earns American Business Award

Quality Systems, Inc. announced today that its Dental Division's NextDDS solution earned the American Business Award (ABA) for best ad campaign in the health products and services category.

28 Jun 2010

Transposons create genomic instability and are implicated in cancer and other diseases: Research

Transposons, or "jumping genes," make up roughly half of the human genome. Geneticists previously estimated that they replicate and insert themselves into new locations roughly one in every 20 live births.

28 Jun 2010

Helicos BioSciences to develop, market MDx tests that utilize HeliScope Single Molecule Sequencer

Helicos BioSciences Corporation announced today that it is in the early stages of validating molecular diagnostic (MDx) tests that utilize its HeliScope® Single Molecule Sequencer. The HeliScope Sequencer's ability to sequence single molecules of natural, unamplified DNA or RNA simplifies the diagnostic testing workflow obviating the need for the amplification steps utilized by most genetic analysis methods.

28 Jun 2010

Spiration to become a consolidated subsidiary of Olympus

Olympus Corporation is pleased to announce that an agreement was reached with Spiration, Inc. (Head Office: Redmond, Washington, U.S.A; President and CEO: Rick Shea) in which all shares of Spiration® will be acquired by Olympus Corporation of the Americas, a North American subsidiary of Olympus.

From Evident Corporation - Life Sciences 25 Jun 2010

Medica, HealthInsight partner to deliver value-based benefit program to commercial customers

Today, Medica, a leading health care insurance provider headquartered in Minneapolis, and HealthInsight, provider of the leading value-based healthcare incentive platform, announced that they have partnered to deliver a next generation value-based benefit program to Medica's commercial customers.

24 Jun 2010

IDEV enters exclusive distribution agreement with TriReme for GliderXtreme PTA balloon catheter

IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme™ PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market.

24 Jun 2010

New research project to review accuracy of medical diagnoses

A new research project at the University of Leicester will review the accuracy of medical diagnoses. Evaluating diagnostic strategy is crucial to clinical practice as it helps maximise the efficacy of the treatments which are offered to patients. Many lives are affected every day by the diagnoses made by hospitals and medical doctors, and it is vital that diagnoses are accurate.

23 Jun 2010

Shift in balance between good and bad bacteria in gut could be a harbinger of colon cancer: Study

The human body contains more bacteria than it does cells. These bacterial communities can have a positive effect on our health, by training our immune systems and helping to metabolize the foods we eat. But they can also set us up to develop digestive disorders, skin diseases, and obesity.

23 Jun 2010

German IVF Register reports one-millionth treatment cycle in reproductive medicine

Dr. Klaus Buhler, President of the German IVF Register, has reported the one-millionth treatment cycle in reproductive medicine recorded by the IVF Register in Germany this year. Presently, ninety per cent of all centers for in-vitro fertilization (IVF) in Germany collect data from reproductive treatments using RecDate Advance by Merck Serono - a database system developed by the IT consulting firm CRITEX, and marketed under the name MedITEX IVF.

23 Jun 2010

Corgenix receives new European patent for AtherOx technology

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).

23 Jun 2010

Next Generation News and Research

BioImagene, KUMC partner to develop Companion Algorithms for digital pathology

Pre-clinical data of BiTE antibody technology published in PNAS

Roche, IBM announce agreement to develop nanopore-based sequencer for decoding human DNA

Biomerix receives FDA 510(k) Clearance to market Ventral Hernia Repair Mesh

SeqWright, RainDance Technologies partner to offer RainStorm microdroplet-based PCR technology

InNexus develops IXS312 small protein fragment as topical therapy for AMD, diabetic retinal dysplasia

Zymeworks closes $3.2 million financing round

PROLOR Biotech receives EU GMP certification for hGH-CTP biobetter version of human growth hormone

FDA grants AMS clearance for MiniArc Precise Single-Incision Sling System

MorphoSys, Xencor sign worldwide exclusive license, collaboration agreement for XmAb5574 antibody program

Quality Systems’ ad campaign for NextDDS solution earns American Business Award

Transposons create genomic instability and are implicated in cancer and other diseases: Research

Helicos BioSciences to develop, market MDx tests that utilize HeliScope Single Molecule Sequencer

Spiration to become a consolidated subsidiary of Olympus

Medica, HealthInsight partner to deliver value-based benefit program to commercial customers

IDEV enters exclusive distribution agreement with TriReme for GliderXtreme PTA balloon catheter

New research project to review accuracy of medical diagnoses

Shift in balance between good and bad bacteria in gut could be a harbinger of colon cancer: Study

German IVF Register reports one-millionth treatment cycle in reproductive medicine

Corgenix receives new European patent for AtherOx technology

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News